Creative Medical Technology Holdings, Inc. (CELZ)

Every figure this model derived for CELZ, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
cash 8,714,115 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2026-06-30
current assets 9,018,913 AssetsCurrent 2026-06-30
current liabilities 698,595 LiabilitiesCurrent 2026-06-30
equity 8,654,972 StockholdersEquity 2026-06-30
interest expense 0 InterestPaidNet 2026-06-30
ocf -5,901,718 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 3,000 Revenues 2026-06-30
sbc 0 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up CELZ on one particular measure came for.

RatioValue
current ratio12.91
current ratio reported12.91
dilution pct61.01
revenue growth-50.0
revenue growth per share-68.95
rule of 40-208054.4
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about CELZ's figures. Written by the derivation as it ran, not added afterwards.